| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 4 |
| 1 | BORTEZOMIB | 3 |
| 2 | CARFILZOMIB | 3 |
| 3 | CYTARABINE | 3 |
| 4 | DEXAMETHASONE | 3 |
| 5 | DEXAMETHASONE 1.5 MG | 3 |
| 6 | LENALIDOMIDE | 3 |
| 7 | THALIDOMIDE | 3 |
| 8 | ACETAMINOPHEN | 2 |
| 9 | ACETAMINOPHEN 500MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUIZARTINIB | 1 | 0.0014 |
| 1 | PRAZOSIN | 2 | 0.0003 |
| 2 | BROLUCIZUMAB | 1 | 0.0003 |
| 3 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| 4 | SACITUZUMAB GOVITECAN | 1 | 0.0002 |
| 5 | ELOTUZUMAB | 1 | 0.0002 |
| 6 | DALTEPARIN SODIUM | 2 | 0.0002 |
| 7 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 8 | VINORELBINE | 1 | 0.0001 |
| 9 | CARFILZOMIB | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 2 | Proteasome Inhibitor [EPC] | 3 | 0.0000 |
| 3 | Histamine-1 Receptor Antagonist [EPC] | 2 | 0.0000 |
| 4 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |
| 5 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 4 | 0.0000 |
| 7 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 9 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |